Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 263

ZStack racks up series B-plus funding

DBappSecurity and existing investor Alibaba Cloud were among the participants in a $33.3m round that will fund product development for the cloud management software provider.

Aug 20, 2020

iKala cashes $17m series B

Gamania-backed cloud marketing technology provider iKala is looking to expand across Asia following a round led by Wistron Digital Technology.

Aug 20, 2020

Matrixtime turns to HYC for series A

Suzhou HYC Technology participated in a $15.9m round for the smart manufacturing technology provider, which counts Guolian Group and SBI as early backers.

Aug 20, 2020

Daily deal net: August 19, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 19, 2020

Konka and Yancheng knock out industry fund

The consumer electronics producer will provide 40% of the capital for a fund partnership with the city of Yancheng sized at up to $1.45bn.

Aug 19, 2020

JD Health books $830m appointment with Hillhouse

Hillhouse Capital is set to supply more than $830m for JD.com's pharmaceutical and medical services spinoff, which raised about $1bn last year.

Aug 19, 2020

CapitaLand closes C31 Ventures

The real estate group terminated the activities of its corporate venture capital fund last year having backed six portfolio companies.

Aug 19, 2020

MDI Ventures impresses with $500m fund

Telkom Indonesia's latest fund will invest up to $30m in domestic digital technology developers that will be able to connect to other state-owned corporations.

Aug 18, 2020

JW Therapeutics to jump to public markets

The immuno-oncology company – co-founded by Juno Therapeutics, a spinout of several institutions – is reportedly seeking $250m to $300m in a Hong Kong offering.

Aug 18, 2020

JW Therapeutics to jump to public markets

WuXi AppTec and Juno Therapeutics' immuno-oncology joint venture is reportedly seeking $250m to $300m in a Hong Kong offering.

Aug 18, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here